The role of IFN-γ in systemic erythematosus: A challenge tothe Th1/Th2 paradigm in autoimmunity

Arthritis Research

Volumn 3, Issue 3, 2001, Pages 136-141

  Theofilopoulos, A N ^a   Koundouris, S ^a   Kono, D H ^a   Lawson, B R ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Cytokines; IFN ; Lupus; Th1; Th2

Indexed keywords

AUTOANTIBODY; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL TYPE; CELLULAR IMMUNITY; CLASSIFICATION; CONTROLLED STUDY; DISEASE MODEL; HELPER CELL; HUMORAL IMMUNITY; HYPOTHESIS; IMMUNE RESPONSE; MOUSE; MOUSE STRAIN; NONHUMAN; NOTE; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ANIMALS; AUTOIMMUNITY; DISEASE MODELS, ANIMAL; DNA, COMPLEMENTARY; GENE THERAPY; IMMUNOGLOBULIN FC FRAGMENTS; INTERFERON TYPE II; INTERLEUKINS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, MUTANT STRAINS; RECEPTOR CROSS-TALK; RECOMBINANT FUSION PROTEINS; TH1 CELLS; TH2 CELLS;

EID: 0035053491     PISSN: 14659905     EISSN: None     Source Type: Journal    
DOI: 10.1186/ar290     Document Type: Note

References (67)

1. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins
2. Differentiation of effector phenotypes of CD4+ and CD8+ T cells
3. Functional diversity of helper T lymphocytes
4. Cytokines induce the development of functionally heterogeneous T helper cell subsets
5. Dynamics of T lymphocyte responses: Intermediates, effectors, and memory cells
6. The role of chemokine receptors in primary, effector, and memory immune responses
7. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes
8. Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production
9. CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function
10. Selective expression of an interleukin-12 receptor component by human T helper 1 cells
11. Developmental commitment to the Th2 lineage by extinction of IL-12 signaling
12. Antibodies to the IL-12 receptor beta 2 chain mark human Th1 but not Th2 cells in vitro and in vivo
13. Selective expression and functions of interleukin 18 receptor on T helper (Th) type 1 but not Th2 cells
14. Complexity or coherence? Cytokine secretion by B cells
15. Reciprocal regulation of polarized cytokine production by effector B and T cells
16. Transcriptional regulation of Th1/Th2 polarization
17. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NFkappaB
18. Differentiation of CD4+ T cells to Th1 cells requires MAP kinase JNK2
19. Tumour necrosis factor and other cytokines in murine lupus
20. Quantitative polymerase chain reaction analysis reveals marked overexpression of interleukin-1 beta, interleukin-1 and interferon-gamma mRNA in the lymph nodes of lupus-prone mice
21. Upregulation of lymphoid and renal interferon-gamma mRNA in autoimmune MRL-Fas(Ipr) mice with lupus nephritis
22. Increased activation and altered ratio of interferon-gamma: Interleukin-4 secreting cells in MRL-Ipr/Ipr mice
23. In vivo cytokine gene expression in T cell subsets of the autoimmune MRL/Mp-Ipr/Ipr mouse
24. Expression of lymphokine genes in splenic lymphocytes of autoimmune mice
25. Enhanced interferon-gamma (IFN) production by lymph node cells from autoimmune (MRL/1, MRL/n) mice
26. IL-12 drives IFN-gamma-dependent autoimmune kidney disease in MRL-Fas(Ipr) mice
27. Up-regulation of tubular epithelial interleukin-12 in autoimmune MRL-Fas(Ipr) mice with renal injury
28. The role of interleukin 12 and nitric oxide in the development of spontaneous autoimmune disease in MRL/Mp-Ipr/Ipr mice
29. Antinuclear autoantibodies and lupus nephritis in transgenic mice expressing interferon gamma in the epidermis
30. A central role for alpha beta T cells in the pathogenesis of murine lupus
31. Levels of IL-12 in the sera of patients with systemic lupus erythematosus (SLE) - Relation to Th1- and Th2-derived cytokines
32. Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis and other rheumatic diseases
33. Th1/Th2 balance of peripheral T helper cells in systemic lupus erythematosus
34. The combination of polymorphisms within interferon-gamma receptor 1 and receptor 2 associated with the risk of systemic lupus erythematosus
35. Hyperinducible expression of the interferon-gamma (IFN-gamma) gene and its suppression in systemic lupus erythematosus (SLE)
36. Interferon-gamma induced exacerbation of systemic lupus erythematosus
37. Lupus-like autoimmune disease induced by interferon therapy for myeloproliferative disorders
38. In vivo treatment of (NZBxNZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon
39. Experimental therapy of systemic lupus erythematosus: The treatment of NZB/W mice with mouse soluble interferon-gamma receptor inhibits the onset of glomerulonephritis
40. In vivo treatment with a monoclonal antivody to interferon-gamma neither affects the survival nor the incidence of lupus-nephritis in the MRL/Ipr-Ipr mouse
41. Roles of interferon-gamma and interleukin-4 in murine lupus
42. Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-Ipr mice
43. IFN-gamma receptor deletion prevents autoantibody production and glomerulonephritis in lupus-prone (NZBxNZW)F1 mice
44. IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(Ipr) mice
45. Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis
46. Genetics of systemic autoimmunity in mouse lupus
47. Treatment of murine lupus with cDNA encoding IFN-gammaR/Fc
48. IFN-gamma receptor-Ig fusion proteins. Half-life, immunogenicity, and in vivo activity
49. Mouse soluble IFN gamma receptor as IFN gamma inhibitor. Distribution, antigenicity, and activity after injection in mice
50. Construction, purification, and characterization of new interferon gamma (IFN gamma) inhibitor proteins. Three IFN gamma receptor-immunoglobulin hybrid molecules
51. The basic science of gene therapy
52. Cell-mediated DNA transport between distant inflammatory sites following intradermal DNA immunization in the presence of adjuvant
53. Roles of IL-4 and IL-12 in the development of lupus in NZB/W F1 mice
54. Modulation of the immunoglobulin dysregulation in GvH- and SLE-like diseases by the murine IL-4 receptor ((L-4-R)
55. Development of lupus in BXSB mice is independent of IL-4
56. Interleukin-4 protects against a genetically linked lupus-like autoimmune syndrome
57. Interleukin-6 exacerbates glomerulonephritis in (NZBxNZW)F1 mice
58. Interleukin 6 promotes murine lupus in NZB/NZW F1 mice
59. Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice
60. Interferon gamma (IFN-gamma) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice
61. The Th2 cytokine IL-4 is not required for the progression of antibody-dependent autoimmune myasthenia gravis
62. Postnatal anti-interferon-gamma treatment prevents pancreatic inflammation in transgenic mice with beta-cell expression of interferon-gamma
63. Transgenic mice expressing IFN-gamma in pancreatic beta-cells are resistant to streptozotocin-induced diabetes
64. Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice
65. The paradoxical effects of interleukin 10 in the immunoregulation of autoimmune diabetes
66. Systemic delivery of interleukin 10 by intramuscular injection of expression plasmid DNA prevents autoimmune diabetes in nonobese diabetic mice
67. IL-10 deficiency does not inhibit insulitis and accelerates cyclophosphamide-induced diabetes in the nonobese diabetic mouse